China Biotech Services Holdings Limited (8037.HK)

HKD 0.38

(0.0%)

Total Debt Summary of China Biotech Services Holdings Limited

  • China Biotech Services Holdings Limited's latest annual total debt in 2023 was 100.39 Million HKD , up 22.76% from previous year.
  • China Biotech Services Holdings Limited's latest quarterly total debt in 2024 Q1 was 155.09 Million HKD , up 54.48% from previous quarter.
  • China Biotech Services Holdings Limited reported annual total debt of 81.78 Million HKD in 2022, up 21.76% from previous year.
  • China Biotech Services Holdings Limited reported annual total debt of 67.17 Million HKD in 2021, down -36.83% from previous year.
  • China Biotech Services Holdings Limited reported quarterly total debt of 155.09 Million HKD for 2024 Q2, up 7.59% from previous quarter.
  • China Biotech Services Holdings Limited reported quarterly total debt of - HKD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Debt Chart of China Biotech Services Holdings Limited (2023 - 2005)

Historical Annual Total Debt of China Biotech Services Holdings Limited (2023 - 2005)

Year Total Debt Total Debt Growth
2023 100.39 Million HKD 22.76%
2022 81.78 Million HKD 21.76%
2021 67.17 Million HKD -36.83%
2020 106.34 Million HKD 151.95%
2019 42.2 Million HKD 766.65%
2018 4.87 Million HKD -84.56%
2017 31.54 Million HKD 43.55%
2016 21.97 Million HKD 1046.27%
2015 1.91 Million HKD -89.92%
2014 19.01 Million HKD -67.87%
2013 59.18 Million HKD 384.01%
2012 12.22 Million HKD -44.94%
2011 22.21 Million HKD 22.54%
2010 18.12 Million HKD -22.47%
2009 23.37 Million HKD -37.7%
2008 37.52 Million HKD 39.75%
2007 26.85 Million HKD 354.39%
2006 5.9 Million HKD -57.68%
2005 13.96 Million HKD 0.0%

Peer Total Debt Comparison of China Biotech Services Holdings Limited

Name Total Debt Total Debt Difference
Life Healthcare Group Limited 5.7 Million HKD -1659.173%